NCT00324415 Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer Status COMPLETED Phase PHASE2
NCT00321100 Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab Status TERMINATED Phase PHASE2
NCT00319839 Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab Status TERMINATED Phase PHASE2
NCT00316888 Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Status COMPLETED Phase PHASE2
NCT00315185 Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer Status COMPLETED Phase PHASE2
NCT00311857 Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) Status UNKNOWN Phase PHASE1/PHASE2
NCT00305877 Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery Status COMPLETED Phase PHASE2
NCT00305760 Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00301028 Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00297128 Preoperative Chemoradiation With Capecitabine and Cetuximab Status COMPLETED Phase PHASE2
NCT00292955 Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Status UNKNOWN Phase PHASE2
NCT00291707 Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00290615 Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00288054 S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00276744 Individualized Drug Treatment for Treating Patients With Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00275041 Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00265941 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3